News for hackers. Stuff that matters.

A comment on Goldman Sachs questions whether curing patients is a sustainable business model. Parent comment

Re:Goldman Sachs questions whether curing patients is a sust... by Bromskloss on Friday April 13, 2018 @04:13PM (#16833522)
The same as for the first drug manufacturer, I suppose. And if you really have a superior product, you should be able to take all the customers, assuming that the customers are smart enough.
[ Parent | on HN ]

There are no comments on this comment yet.